For research teamsHelp me find a study
Back to all studies
CompletedNCT06792136

ONO-1110 for depression

This study is completed in Japan. It is testing ONO-1110 for depression.

DepressionDrugFrom 18 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT06792136. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

Check the official registry

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Japan · 29 sites
  • AK Clinic
    Fukuoka
    Site status: Not listed — confirm with the team
  • Hiro Mental Clinic
    Fukuoka
    Site status: Not listed — confirm with the team
  • Hirota Clinic
    Fukuoka
    Site status: Not listed — confirm with the team
  • Kokorono Clinic Hirao
    Fukuoka
    Site status: Not listed — confirm with the team
  • Kokorono Clinic Iizuka
    Fukuoka
    Site status: Not listed — confirm with the team
  • Kokura Mental Clinic
    Fukuoka
    Site status: Not listed — confirm with the team
  • Mental Clinic Sakurazaka
    Fukuoka
    Site status: Not listed — confirm with the team
  • Shinseikai Kaku Mental Clinic
    Fukuoka
    Site status: Not listed — confirm with the team
  • Uematsu Mental Clinic
    Fukuoka
    Site status: Not listed — confirm with the team
  • Ichikawa Clinic
    Gunma
    Site status: Not listed — confirm with the team
  • Higashi-Sapporo Mental Clinic
    Hokkaido
    Site status: Not listed — confirm with the team
  • Kawamura Mental Clinic
    Hokkaido
    Site status: Not listed — confirm with the team
  • Minami1jo Mental Clinic
    Hokkaido
    Site status: Not listed — confirm with the team
  • Sapporo Kobushi Clinic
    Hokkaido
    Site status: Not listed — confirm with the team
  • Shimode Mental Clinic
    Hokkaido
    Site status: Not listed — confirm with the team
  • Tatsuta Clinic
    Hyōgo
    Site status: Not listed — confirm with the team
  • Kishiro Mental Clinic
    Kanagawa
    Site status: Not listed — confirm with the team
  • Yutaka Clinic
    Kanagawa
    Site status: Not listed — confirm with the team
  • Harai Clinic
    Tokyo
    Site status: Not listed — confirm with the team
  • Iidabashi Mental Clinic
    Tokyo
    Site status: Not listed — confirm with the team
  • Ikebukuro Olive Mental Clinic
    Tokyo
    Site status: Not listed — confirm with the team
  • Kitaikebukuro Kokoro No Clinic
    Tokyo
    Site status: Not listed — confirm with the team
  • Maynds Tower Mental Clinic
    Tokyo
    Site status: Not listed — confirm with the team
  • Meguroeki Higashiguchi Mental Clinic
    Tokyo
    Site status: Not listed — confirm with the team
  • Monzen-nakacho Mental Clinic
    Tokyo
    Site status: Not listed — confirm with the team
  • Niseikai Murakami Iin
    Tokyo
    Site status: Not listed — confirm with the team
  • Nishi-Shinjuku Concieria Clinic
    Tokyo
    Site status: Not listed — confirm with the team
  • Sakurazaka Clinic SophyAnce
    Tokyo
    Site status: Not listed — confirm with the team
  • Sangenjaya Nakamura Mental Clinic
    Tokyo
    Site status: Not listed — confirm with the team
In plain English

Key information made simple

What is this study testing?

This study is testing whether ONO-1110 may be useful for adults experiencing depression.

What would participation involve?

Participants may receive ONO-1110, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Japan.

Who is it mainly for?

This study appears to be mainly for adults with depression.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

Study sites are listed in the registry. Recruitment status can differ between sites. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: January 16, 2025
Recruitment status
Completed
Enrollment listed in the registry
103
Sponsor
Ono Pharmaceutical Co., Ltd.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Japan
Age range
From 18 Years to 65 Years
Official registry ID
NCT06792136
Official title
A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Major Depressive Disorder
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT06792136. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving ONO-1110, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with depression; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Ono Pharmaceutical Co., Ltd., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.